Celltrion's FDA approval of Steqeyma enhances pediatric psoriasis treatment, offering flexible dosing options for children ...

The Food and Drug Administration has designated Hadlima (adalimumab-bwwd) an interchangeable biosimilar to Humira (adalimumab).

New research highlights the efficacy and high patient satisfaction of adalimumab biosimilars in treating inflammatory ...

Switching to Humira biosimilars saved Navitus clients more than $315 million in upfront costs in 2024 and resulted in a 60% ...

The FDA has expanded the interchangeable designation for Yuflyma (adalimumab-aaty), a biosimilar to Humira, to include all presentations.

Some Michigan hospitals are marking up prescription drug prices by 800% above what they they pay manufacturers, according to a new report from the Michigan Health Purchasers Coalition.

In this article, we are going to take a look at where Organon & Co. (NYSE:OGN) stands against other best-performing stocks. Organon rallied for a third consecutive day on Thursday, jumping 4.26 ...

Most of the time, psoriasis is the first symptom of psoriatic arthritis. It causes silvery-white skin lesions called plaques, which may appear on your scalp, elbows, knees, and lower back. Eventually, ...

Psoriatic arthritis (PsA) is a chronic (long-lasting) condition that combines the skin-related symptoms of psoriasis with the joint-related symptoms of arthritis. PsA is an autoimmune disease ...

Psoriatic arthritis (PsA) has been around for thousands of years. Archaeologists unearthed Egyptian mummies with signs of the disease. Back then, the treatments for swollen and painful joints and ...

Psoriatic arthritis is a chronic inflammatory arthritis. Psoriasis is an autoimmune condition that causes inflammation in your skin and may cause inflammation in and around your joints ...